Skip to content
pH Pharma
  • About Us
    • Who We Are
    • Our History
    • Leadership
    • Our Strategy
    • Our Partners
  • Pipeline
    • All Programs
    • ADC
    • Sovesudil
  • Media
  • Careers
  • Contact Us
en_US EN
en_US EN ko_KR KR

Day: May 1, 2022

Regeneration of Corneal Endothelial Cells using pH Pharma’s ROCK Inhibitors presented at ARVO Annual Meeting

By AdminIn NewsPosted 2022-05-01

Results showing corneal endothelial cell regeneration with sovesudil (starting phase III clinical trial for glaucoma; also known as PHP-201) and PHP-961 was presented at the Association for Research in Vision and Ophthalmology Annual Meeting May 1st – 5th, 2022 (ARVO 2022). This study was conducted at Hallym University in collaboration...

More

Recent Posts

  • Regeneration of Corneal Endothelial Cells using pH Pharma’s ROCK Inhibitors presented at ARVO Annual Meeting
  • 신주발행 공고
  • 분할 공고
  • 구주권 제출 및 실효 공고
  • 기준일 및 명의개서 정지기간 설정공고

Recent Comments

    pH Pharma
    Copyright © 2023 pH Pharma | All Rights Reserved
    pH Pharma Co. LTD.

    B-1009, U-Space 2, 670 Daewangpangyo-ro,
    Bundang-gu, Seongnam-si, Gyeonggi-do 13494

    (+82) 31-779-5330

    Contact

    LinkedIn